Helio

Curated by Signal

Developer of AI-based diagnostic test for the early detection of cancer

Overview

Developer of AI-based diagnostic test for the early detection of cancer. The company uses artificial intelligence and machine learning to identify unique and proprietary DNA signatures and develops multi-analyte blood tests. The company's flagship product is the HelioLiver test for the early detection of liver cancer.

Key facts

Founded: 2000
Headquarters: Irvine, United States
Stage: Sign up to view
Industry: Health Technology

Business model

9 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Physician Sign Out
HIPAA-compliant, online patient sign out system for providers
Health TechnologyAustin, United States
Meddit
AI driven platform offering solutions for clinical decisions
Health TechnologyBoston, United States
Innobot Health
AI and cloud-based revenue cycle workflow management tool
Health TechnologyMoreno Valley, United States

About Helio

What does Helio do?

Developer of AI-based diagnostic test for the early detection of cancer.

Where is Helio headquartered?

Helio is headquartered in Irvine, United States.

When was Helio founded?

Helio was founded in 2000.

Which sector is Helio in?

Helio operates in Health Technology.

Who are Helio's competitors?

Companies similar to Helio include Physician Sign Out, Meddit, and Innobot Health.